319 related articles for article (PubMed ID: 24828559)
1. The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors.
Moteabbed M; Yock TI; Paganetti H
Phys Med Biol; 2014 Jun; 59(12):2883-99. PubMed ID: 24828559
[TBL] [Abstract][Full Text] [Related]
2. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
[TBL] [Abstract][Full Text] [Related]
4. Does VMAT for treatment of NSCLC patients increase the risk of pneumonitis compared to IMRT ? - a planning study.
Bertelsen A; Hansen O; Brink C
Acta Oncol; 2012 Jul; 51(6):752-8. PubMed ID: 22248064
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT.
Lee B; Lee S; Sung J; Yoon M
J Radiol Prot; 2014 Jun; 34(2):325-31. PubMed ID: 24705154
[TBL] [Abstract][Full Text] [Related]
6. Volumetric-modulated arc radiotherapy for skull-base and non-skull-base head and neck cancer: a treatment planning comparison with fixed Beam IMRT.
Chen J; Mok E; Wang L; Chen C; Le QT
Technol Cancer Res Treat; 2013 Feb; 12(1):11-8. PubMed ID: 22905805
[TBL] [Abstract][Full Text] [Related]
7. Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy.
Fogliata A; De Rose F; Franceschini D; Stravato A; Seppälä J; Scorsetti M; Cozzi L
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):785-793. PubMed ID: 29249528
[TBL] [Abstract][Full Text] [Related]
8. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk.
Filippi AR; Ragona R; Piva C; Scafa D; Fiandra C; Fusella M; Giglioli FR; Lohr F; Ricardi U
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):161-8. PubMed ID: 25863763
[TBL] [Abstract][Full Text] [Related]
9. Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes.
Zwahlen DR; Bischoff LI; Gruber G; Sumila M; Schneider U
Radiat Oncol; 2016 Nov; 11(1):149. PubMed ID: 27832799
[TBL] [Abstract][Full Text] [Related]
10. Secondary cancer risk after whole-breast radiation therapy: field-in-field versus intensity modulated radiation therapy versus volumetric modulated arc therapy.
Haciislamoglu E; Cinar Y; Gurcan F; Canyilmaz E; Gungor G; Yoney A
Br J Radiol; 2019 Oct; 92(1102):20190317. PubMed ID: 31295011
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiation therapy and volumetric-modulated arc therapy for adult craniospinal irradiation--a comparison with traditional techniques.
Studenski MT; Shen X; Yu Y; Xiao Y; Shi W; Biswas T; Werner-Wasik M; Harrison AS
Med Dosim; 2013; 38(1):48-54. PubMed ID: 22878118
[TBL] [Abstract][Full Text] [Related]
12. Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses.
Nguyen J; Moteabbed M; Paganetti H
Med Phys; 2015 Jan; 42(1):81-9. PubMed ID: 25563249
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
Hall EJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience transitioning from IMRT to VMAT for head and neck cancer.
Studenski MT; Bar-Ad V; Siglin J; Cognetti D; Curry J; Tuluc M; Harrison AS
Med Dosim; 2013; 38(2):171-5. PubMed ID: 23246253
[TBL] [Abstract][Full Text] [Related]
15. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
[TBL] [Abstract][Full Text] [Related]
16. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
[TBL] [Abstract][Full Text] [Related]
17. A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques.
Johansen S; Cozzi L; Olsen DR
Acta Oncol; 2009; 48(4):495-503. PubMed ID: 19169915
[TBL] [Abstract][Full Text] [Related]
18. Single Arc Volumetric Modulated Arc Therapy of head and neck cancer.
Bertelsen A; Hansen CR; Johansen J; Brink C
Radiother Oncol; 2010 May; 95(2):142-8. PubMed ID: 20188427
[TBL] [Abstract][Full Text] [Related]
19. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
Seco J; Gu G; Marcelos T; Kooy H; Willers H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for pancreatic malignancies.
Ali AN; Dhabaan AH; Jarrio CS; Siddiqi AK; Landry JC
Med Dosim; 2012; 37(3):271-5. PubMed ID: 22189026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
